‪Yasmin Maor‬‏

7.0k total citations · 2 hit papers
112 papers, 3.7k citations indexed

About

‪Yasmin Maor‬‏ is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, ‪Yasmin Maor‬‏ has authored 112 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Epidemiology, 29 papers in Infectious Diseases and 17 papers in Hepatology. Recurrent topics in ‪Yasmin Maor‬‏'s work include Liver Disease Diagnosis and Treatment (14 papers), Hepatitis C virus research (13 papers) and COVID-19 Clinical Research Studies (12 papers) ‪Yasmin Maor‬‏ is often cited by papers focused on Liver Disease Diagnosis and Treatment (14 papers), Hepatitis C virus research (13 papers) and COVID-19 Clinical Research Studies (12 papers) ‪Yasmin Maor‬‏ collaborates with scholars based in Israel, United States and France ‪Yasmin Maor‬‏'s co-authors include Dan Aderka, Hartmut Engelmann, David Wallach, Cord Brakebusch, Nathan Keller, Stephen Malnick, Galia Rahav, Benjamin Mozes, Debby Ben-David and Liraz Olmer and has published in prestigious journals such as The Lancet, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

‪Yasmin Maor‬‏

109 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors.

1992 705 citations ‪Yasmin Maor‬‏ et al. profile →
BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel

2021 199 citations Tal Brosh‐Nissimov, Efrat Orenbuch‐Harroch et al. Clinical Microbiology and Infection profile →

Peers

Countries citing papers authored by ‪Yasmin Maor‬‏

Since Specialization

Citations

This map shows the geographic impact of ‪Yasmin Maor‬‏'s research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by ‪Yasmin Maor‬‏ with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites ‪Yasmin Maor‬‏ more than expected).

Fields of papers citing papers by ‪Yasmin Maor‬‏

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by ‪Yasmin Maor‬‏. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by ‪Yasmin Maor‬‏. The network helps show where ‪Yasmin Maor‬‏ may publish in the future.

Co-authorship network of co-authors of ‪Yasmin Maor‬‏

This figure shows the co-authorship network connecting the top 25 collaborators of ‪Yasmin Maor‬‏. A scholar is included among the top collaborators of ‪Yasmin Maor‬‏ based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with ‪Yasmin Maor‬‏. ‪Yasmin Maor‬‏ is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Outcomes and Healthcare Resource Utilization in Patients with COVID-19 Treated with Nirmatrelvir–Ritonavir: Real-World Data Analysis 2024 ·Journal of Clinical Medicine ·Clara Weil, Lilac Tene, Gabriel Chodick, Noga Fallach, Wajeeha Ansari, (unknown), ‪Yasmin Maor‬‏	0
2	Virulence factors, antibiotic susceptibility and sequence type distribution of hospital-associated Clostridioides difficile isolates in Israel, 2020–2022 2024 ·Scientific Reports ·Orna Schwartz, (unknown), (unknown), (unknown), (unknown), ‪Yasmin Maor‬‏, Lior Nesher, Orli Sagi, Avi Peretz	2
3	Immunobridging Trials: An Important Tool to Protect Vulnerable and Immunocompromised Patients Against Evolving Pathogens 2024 ·Vaccines ·(unknown), Jie Min Lam, Jehad Abdalla, Samira Bell, (unknown), Tal Brosh‐Nissimov, John S. Gill, Ghady Haidar, Michael Hoerger, ‪Yasmin Maor‬‏, Antonio Pagliuca, François Raffi, (unknown), Dorry L. Segev, (unknown), Lennard Y. W. Lee	2
4	Current management strategies for multidrug-resistant Gram-negative urinary tract infections, a focus on aminoglycosides monotherapy 2024 ·SHILAP Revista de lepidopterología ·(unknown), ‪Yasmin Maor‬‏, (unknown), Dafna Yahav	4
5	Group B streptococcus virulence factors associated with different clinical syndromes: Asymptomatic carriage in pregnant women and early-onset disease in the newborn 2023 ·Frontiers in Microbiology ·(unknown), Galia Rahav, Israel Nissan, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), ‪Yasmin Maor‬‏	9
6	Predictors of reinfection with pre-Omicron and Omicron variants of concern among individuals who recovered from COVID-19 in the first year of the pandemic 2023 ·International Journal of Infectious Diseases ·Dani Cohen, Marina Izak, Evgeniy Stoyanov, Michal Mandelboim, (unknown), (unknown), Sophy Goren, Anya Bialik, Limor Kliker, (unknown), (unknown), (unknown), Hadar Marcus, (unknown), Tomer Israely, Nir Paran, Oren Zimhony, Eilat Shinar, ‪Yasmin Maor‬‏, Khitam Muhsen	9
7	Hospitalized Patients With Severe Coronavirus Disease 2019 During the Omicron Wave in Israel: Benefits of a Fourth Vaccine Dose 2022 ·Clinical Infectious Diseases ·Tal Brosh‐Nissimov, Khetam Hussein, Yonit Wiener‐Well, Efrat Orenbuch‐Harroch, Meital Elbaz, (unknown), ‪Yasmin Maor‬‏, (unknown), Bibiana Chazan, (unknown), Galia Rahav, Oren Zimhony, (unknown), Michal Chowers	25
8	Predictors of mortality in COVID-19 patients treated with convalescent plasma therapy 2022 ·PLoS ONE ·Naomi Rahimi‐Levene, (unknown), Irma Tzur, (unknown), Victoria Peer, (unknown), Marina Izak, Eilat Shinar, Tomer Ziv‐Baran, Miriam Weinberger, Oren Zimhony, Jacob Chen, ‪Yasmin Maor‬‏	4
9	Attitudes towards influenza, and COVID-19 vaccines during the COVID-19 pandemic among a representative sample of the Jewish Israeli population 2022 ·PLoS ONE ·‪Yasmin Maor‬‏, (unknown)	7
10	Missed opportunities for earlier diagnosis of HIV in patients who presented with advanced HIV disease: a retrospective cohort study 2016 ·BMJ Open ·Itzchak Levy, ‪Yasmin Maor‬‏, Naim Mahroum, Liraz Olmer, (unknown), (unknown), Orna Mor, Galia Rahav	41
11	Non-Alcoholic Steatohepatitis: Clinical and Translational Research 2016 ·Journal of Pharmacy & Pharmaceutical Sciences ·Manuela G. Neuman, M Voiculescu, Radu M. Nanau, ‪Yasmin Maor‬‏, Ehud Melzer, Lawrence B. Cohen, (unknown), Stephen Malnick	7
12	Primary Versus Nonprimary West Nile Virus Infection: A Cohort Study 2015 ·The Journal of Infectious Diseases ·Galia Rahav, (unknown), ‪Yasmin Maor‬‏, Gilad Yahalom, Musa Hindiyeh, Ella Mendelson, Hanna Bin	1
13	Chronic Hepatitis C in the Aged: Much Ado About Nothing or Nothing to Do? 2014 ·Drugs & Aging ·Stephen Malnick, ‪Yasmin Maor‬‏, Ehud Melzer, Sari Tal	7
14	Efficacy of Liraglutide in a Real-Life Cohort 2014 ·Diabetes Therapy ·Anthony Heymann, ‪Yasmin Maor‬‏, (unknown), Lora Todorova, (unknown), Avraham Karasik	17
15	Celiac Disease Resolution After Allogeneic Bone Marrow Transplantation is Associated with Absence of Gliadin-Specific Memory Response by Donor-Derived Intestinal T-cells 2013 ·Journal of Clinical Immunology ·Shomron Ben‐Horin, Sylvie Polak‐Charcon, Iris Barshack, Orit Picard, Ella Fudim, Miri Yavzori, Camila Avivi, (unknown), Avichai Shimoni, Yehuda Chowers, ‪Yasmin Maor‬‏	7
16	Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections 2011 ·Clinical Microbiology and Infection ·Debby Ben-David, (unknown), Nathan Keller, Ilana Tal, Alex Marzel, Ohad Gal‐Mor, ‪Yasmin Maor‬‏, G. Rahav	277
17	Long-Term Clinical Outcome of Patients with Gastric Gastrointestinal Stromal Tumors 2010 ·Digestive Diseases and Sciences ·‪Yasmin Maor‬‏, Benjamin Avidan, Ehud Melzer, Simon Bar–Meir	4
18	Changing parents’ opinions regarding antibiotic use in primary care 2010 ·European Journal of Pediatrics ·(unknown), ‪Yasmin Maor‬‏, Meir Raz, Ethan Rubinstein, (unknown), (unknown), (unknown), Galia Rahav, Gili Regev‐Yochay	14
19	Treatment of hepatitis C in patients with haemophilia – the Israeli National Hemophilia Center experience 2008 ·Haemophilia ·‪Yasmin Maor‬‏, Jonathan Schapiro, Dalia Bashari, Yoav Lurie, Rifaat Safadi, Ori Segol, (unknown), (unknown), Benjamin Avidan, Simon Bar–Meir, U. Martinowitz	7
20	Endosonographic evaluation of perianal fistulas and abscesses: comparison of two instruments and assessment of the role of hydrogen peroxide injection 2005 ·Journal of Clinical Ultrasound ·‪Yasmin Maor‬‏, Yehuda Chowers, Moshe Koller, Oded Zmora, Simon Bar–Meir, Benjamin Avidan	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact